newsfilter
← Latest News
GlobeNewswire·

Calidi Biotherapeutics Announces Pricing of $6 Million Underwritten Public Offering

SAN DIEGO, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE:CLDI) ("Calidi" or the "Company"), a clinical-stage biotechnology company pioneering the development of targeted therapies with the